Loading insider details...
Latest Form 4 (Nov 6, 2026): Grant/Award of 42,209 RPRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 42,209 | n/a |
| Aug 7, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 65,216 | n/a |
| May 29, 2026 | PROKIDNEY CORP. (PROK) | Grant/Award | 135,000 | n/a |
| May 8, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 143,821 | n/a |
| Feb 13, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 157,828 | n/a |
| Nov 7, 2025 | Royalty Pharma plc (RPRX) | Grant/Award | 36,559 | n/a |
| Aug 8, 2025 | Royalty Pharma plc (RPRX) | Grant/Award | 21,901 | n/a |
| Jun 5, 2025 | PROKIDNEY CORP. (PROK) | Conversion | 3,823,996 | n/a |
| Jun 2, 2025 | PROKIDNEY CORP. (PROK) | Grant/Award | 125,862 | n/a |
| May 20, 2025 | Royalty Pharma plc (RPRX) | Other (see footnotes) | 530,348 | n/a |